I. Activation of NF-κB:
1. Signaling Pathways: NF-κB activation can be triggered by a diverse array of stimuli, including cytokines, microbial components, stress signals, and inflammatory mediators. These stimuli activate specific signaling pathways, such as the Toll-like receptor (TLR) pathway or the tumor necrosis factor (TNF) receptor pathway.
2. IKK Complex Formation: Activation of these signaling pathways leads to the formation of the IκB kinase (IKK) complex, which consists of two catalytic subunits (IKKα and IKKβ) and a regulatory subunit (IKKγ/NEMO).
3. Phosphorylation and Degradation of IκB: The IKK complex phosphorylates inhibitor of NF-κB (IκB), a protein that binds to and sequesters NF-κB in the cytoplasm. Phosphorylation of IκB marks it for degradation by the proteasome.
II. Nuclear Translocation of NF-κB:
1. Release of NF-κB: Once IκB is degraded, NF-κB is released from its inhibitory complex and translocates from the cytoplasm to the nucleus.
2. Nuclear Import: The nuclear translocation of NF-κB is facilitated by its interaction with importins, proteins responsible for transporting molecules into the nucleus.
III. DNA Binding and Transcriptional Activation:
1. Formation of NF-κB Dimers: In the nucleus, NF-κB forms homo- or heterodimers, most commonly the p50/p65 heterodimer. These dimers bind to specific DNA sequences known as κB (kappa B) sites within the promoters of target genes.
2. Coactivator Recruitment: Binding of NF-κB to κB sites recruits various coactivators, proteins that help enhance transcription. This recruitment leads to the assembly of a transcription initiation complex.
3. Transcriptional Activation: The transcription initiation complex facilitates the transcription of target genes into messenger RNA (mRNA), which is then translated into proteins. These proteins mediate the cellular responses associated with NF-κB activation, such as inflammation, immunity, and apoptosis.
IV. Negative Feedback Regulation:
1. Induction of IκBα: To prevent excessive NF-κB activity, negative feedback mechanisms are in place. One such mechanism involves the induction of IκBα, an inhibitor of NF-κB. IκBα is itself a target gene of NF-κB, and its induction leads to the sequestration of newly synthesized NF-κB, thereby limiting its activity.
2. Deubiquitination and Stabilization of IκB: Additionally, IκB can be stabilized by deubiquitination, a process that removes ubiquitin tags that mark proteins for degradation. Deubiquitination enzymes, such as A20, can reverse the ubiquitination of IκB, preventing its degradation and allowing it to bind and inhibit NF-κB.
In summary, the regulation of NF-κB involves a tightly controlled series of events, ranging from its activation by various stimuli to its nuclear translocation, DNA binding, and transcriptional activation of target genes. Negative feedback mechanisms ensure that NF-κB activity is appropriately balanced, maintaining immune homeostasis and preventing excessive inflammation. Dysregulation of NF-κB signaling has been implicated in various diseases, including inflammatory disorders, autoimmune diseases, and cancer.
